User profiles for Dimitris Repantis

Dimitris Repantis

Charité - Universitätsmedizin Berlin, Department of Psychiatry and Neurosciences, Campus …
Verified email at charite.de
Cited by 2426

[HTML][HTML] Single-dose psilocybin for a treatment-resistant episode of major depression

…, A van Reemst, F Reinholdt, D Repantis… - … England Journal of …, 2022 - Mass Medical Soc
Background Psilocybin is being studied for use in treatment-resistant depression. Methods
In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant …

Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review

D Repantis, P Schlattmann, O Laisney… - Pharmacological research, 2010 - Elsevier
The term neuroenhancement refers to improvement in the cognitive, emotional and
motivational functions of healthy individuals through, inter alia, the use of drugs. Of known …

Antidepressants for neuroenhancement in healthy individuals: a systematic review

D Repantis, P Schlattmann, O Laisney, I Heuser - Poiesis & Praxis, 2009 - Springer
Neuroenhancement offers the prospect of improving the cognitive, emotional and motivational
functions of healthy individuals. Of all the conceivable interventions, psychopharmacology …

Non-pharmacological cognitive enhancement

…, A Mroczko-Wąsowicz, S Kühn, D Repantis - …, 2013 - Elsevier
The term “cognitive enhancement” usually characterizes interventions in humans that aim to
improve mental functioning beyond what is necessary to sustain or restore good health. …

[HTML][HTML] Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of …

…, S Mistry, T Páleníček, O Redjep, D Repantis… - Journal of affective …, 2023 - Elsevier
Background COMP360 is a proprietary, synthetic formulation of psilocybin being developed
for treatment-resistant depression (TRD), a burdensome, life-threatening illness with high …

Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review

D Repantis, O Laisney, I Heuser - Pharmacological research, 2010 - Elsevier
The term neuroenhancement refers to improvement in the cognitive, emotional and
motivational functions of healthy individuals through, inter alia, the use of drugs. Of known …

Hacking the brain: dimensions of cognitive enhancement

…, S Kühn, D Repantis - ACS chemical …, 2018 - ACS Publications
In an increasingly complex information society, demands for cognitive functioning are
growing steadily. In recent years, numerous strategies to augment brain function have been …

[HTML][HTML] Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine

D Repantis, L Bovy, K Ohla, S Kühn, M Dresler - Psychopharmacology, 2021 - Springer
Rational At all times humans have made attempts to improve their cognitive abilities by
different means, among others, with the use of stimulants. Widely available stimulants such as …

Feeling smart: Effects of caffeine and glucose on cognition, mood and self-judgment

S Ullrich, YC de Vries, S Kühn, D Repantis… - Physiology & …, 2015 - Elsevier
During education and early career, young adults often face examinations and assessment
centers. Coffee and energy drinks are convenient and commonly used to enhance or maintain …

[HTML][HTML] Moral psychopharmacology needs moral inquiry: the case of psychedelics

…, E Dyck, M Scheidegger, D Repantis - Frontiers in Psychiatry, 2021 - frontiersin.org
The revival of psychedelic research coincided and more recently conjoined with
psychopharmacological research on how drugs affect moral judgments and behaviors. This article …